|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1018
|
$944B |
14.8x |
32.7x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$249
|
$627B |
6.7x |
17.5x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$234
|
$476B |
7.8x |
18.2x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 364
|
$395B |
5.0x |
12.6x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 130
|
$342B |
6.1x |
14.8x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£153
|
$341B |
5.8x |
16.8x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$121
|
$335B |
5.2x |
11.2x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$386
|
$253B |
7.0x |
14.3x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$150
|
$202B |
6.9x |
12.6x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$201B |
3.2x |
8.1x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 237
|
$181B |
3.8x |
7.8x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$62
|
$163B |
3.4x |
8.7x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£22
|
$136B |
3.1x |
9.3x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€81
|
$129B |
2.4x |
8.2x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$486
|
$119B |
9.9x |
22.0x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 10145
|
$99.9B |
12.7x |
24.8x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€41
|
$84.8B |
1.6x |
7.6x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5794
|
$84.2B |
2.9x |
10.9x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$791
|
$77.7B |
5.5x |
15.5x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€126
|
$74.9B |
3.0x |
10.5x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$129
|
$61.4B |
6.5x |
14.9x |
|
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$57.5B |
3.9x |
15.4x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 105
|
$53.2B |
3.0x |
10.1x |
|
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 148
|
$46.9B |
8.9x |
38.5x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 55
|
$46.8B |
9.7x |
32.3x |
|
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€50
|
$46.0B |
1.7x |
10.3x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1764
|
$43.6B |
7.1x |
24.9x |
|
argenx
|
Belgium |
Drug Development & Therapeutics
|
€649
|
$43.1B |
10.3x |
36.2x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 68
|
$41.6B |
3.7x |
17.1x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$325
|
$41.5B |
11.1x |
59.1x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 10445
|
$32.9B |
2.1x |
8.8x |
|
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 193
|
$32.5B |
6.2x |
62.1x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2935
|
$32.1B |
2.5x |
12.1x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$16
|
$31.6B |
2.2x |
7.7x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2485
|
$31.1B |
2.5x |
10.3x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$146
|
$30.7B |
59.7x |
-27.4x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$188
|
$30.4B |
3.1x |
10.0x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 34
|
$22.2B |
10.6x |
27.5x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 8
|
$21.7B |
2.1x |
6.0x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1868
|
$21.7B |
5.9x |
15.6x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$514
|
$19.0B |
5.9x |
11.4x |
|
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6396
|
$18.2B |
16.1x |
49.4x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$17.9B |
4648.8x |
-15.8x |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 83
|
$17.3B |
8.9x |
99.3x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$17.2B |
2.0x |
8.1x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 287
|
$16.9B |
53.9x |
N/A |
|
Torrent Pharmaceuticals
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 4419
|
$16.5B |
12.0x |
36.4x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$16.5B |
3.5x |
18.5x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$53
|
$16.4B |
8.6x |
-5.1x |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$100
|
$16.4B |
3.3x |
10.3x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 389
|
$15.8B |
5.1x |
13.2x |
|
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$28
|
$15.7B |
854.2x |
-14.0x |
|
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 3553
|
$15.6B |
5.1x |
12.6x |
|
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€206
|
$15.1B |
N/A |
N/A |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€164
|
$15.1B |
3.4x |
9.0x |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$190
|
$14.7B |
3.5x |
15.6x |
|
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 168
|
$14.6B |
10.1x |
31.9x |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$65
|
$14.0B |
28.3x |
-30.5x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€47
|
$13.7B |
4.5x |
11.9x |
|
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$13.0B |
N/A |
N/A |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 24
|
$12.8B |
2.1x |
13.3x |
|
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 10
|
$12.6B |
3.2x |
12.7x |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$82
|
$12.5B |
14.0x |
-33.9x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 6
|
$12.3B |
2.6x |
9.6x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$132
|
$12.2B |
4.3x |
18.5x |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 105
|
$12.0B |
25.4x |
-1194.5x |
|
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$16
|
$11.9B |
N/A |
-11.6x |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 417
|
$11.8B |
42.3x |
-255.8x |
|
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.8B |
0.3x |
5.0x |
|
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1295
|
$11.6B |
3.1x |
12.8x |
|
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2292
|
$11.4B |
4.1x |
16.2x |
|
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€67
|
$11.3B |
5.1x |
13.7x |
|
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$11.0B |
99.2x |
N/A |
|
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1352
|
$10.8B |
3.4x |
14.3x |
|
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2280
|
$10.8B |
7.1x |
28.3x |
|
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$60
|
$10.6B |
3.3x |
14.3x |
|
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 919
|
$10.3B |
3.8x |
13.6x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$70
|
$10.2B |
7.6x |
11.7x |
|
Samchundang Pharm
|
South Korea |
Drug Development & Therapeutics
|
KRW 639000
|
$10.2B |
N/A |
N/A |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$107
|
$10.2B |
3.3x |
-8.3x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$9.9B |
1.6x |
5.2x |
|
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$9.8B |
4.2x |
10.4x |
|
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$436
|
$9.1B |
9.6x |
-31.0x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$337
|
$9.1B |
30365.3x |
-30.5x |
|
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 36
|
$8.9B |
1.4x |
11.0x |
|
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€100
|
$8.6B |
845.0x |
-35.8x |
|
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5098
|
$8.6B |
1.7x |
13.7x |
|
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$166
|
$8.4B |
13.4x |
-51.3x |
|
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$64
|
$8.4B |
11.6x |
209.7x |
|
Salubris Pharmaceuticals
|
China |
Drug Development & Therapeutics,
Medical Devices
|
CNY 51
|
$8.0B |
12.2x |
50.3x |
|
Kyowa Kirin Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2808
|
$7.9B |
2.6x |
11.5x |
|
Haisco Pharmaceutical
|
China |
Drug Development & Therapeutics
|
CNY 48
|
$7.9B |
12.2x |
70.5x |
|
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$61
|
$7.7B |
96.2x |
-12.8x |
|
Caliway Biopharmaceuticals
|
Taiwan |
Drug Development & Therapeutics
|
TWD 160
|
$7.7B |
6367.5x |
-276.8x |
|
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€232
|
$7.6B |
3.2x |
9.6x |
|
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1211
|
$7.5B |
2.1x |
10.2x |
|
Sumitomo Pharma
|
Japan |
Drug Development & Therapeutics
|
JPY 2421
|
$7.3B |
2.7x |
9.9x |
|
ABL Bio
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 194600
|
$7.3B |
93.5x |
16374.8x |
|
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 38
|
$7.2B |
N/A |
N/A |
|
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2543
|
$7.2B |
2.3x |
9.6x |